Skip to main content

Advertisement

Log in

Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Antibody-mediated encephalitides constitute a group of inflammatory brain diseases characterized by prominent neuropsychiatric symptoms and are associated with antibodies against neuronal cell-surface proteins, ion channels, or receptors. The diagnosis and management of autoimmune encephalitis include evaluation of the clinical presentation, brain imaging, cerebrospinal fluid (CSF) findings, antibody detection, and electroencephalography (EEG) findings. This is a retrospective study of adults 18 years or older with autoimmune encephalitis due to antibodies against membrane surface antigens as well as anti-glutamic acid decarboxylase (anti-GAD) antibodies. The electronic medical record was reviewed for demographic data, clinical data, laboratory results, EEG, and imaging findings. Antibody screening was requested for 341 patients between May 2014 and December 2019. Antibody screening was positive in 37 patients presenting with seizures and/or encephalopathy. Of these, 10 patients tested positive for antibodies against neuronal surface antigens or anti-GAD antibodies―2 patients had anti-GAD antibody encephalitis, 5 had anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, and 3 had anti-leucine-rich glioma-inactivated 1 (anti-LGI1) encephalitis. Demographics, clinical presentation, EEG, imaging, and CSF findings are reported. Autoimmune encephalitides are a diverse group of disorders with a few common clinical features and MRI findings. MRI, EEG, and CSF findings can be normal or show nonspecific findings in autoimmune encephalitis. Therefore, early diagnosis of these disorders requires a high level of suspicion to avoid delaying the diagnosis. Carefully looking for diagnostic clinical features (e.g., faciobrachial dystonic seizures in anti-LGI1 encephalitis), significant findings in MRI (e.g., limbic encephalitis), and some EEG patterns (e.g., extreme delta brush and generalized rhythmic delta activity in anti-NMDAR encephalitis) may help in early diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Dalmau J (2016) NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias Lecture. Neurology 87(23):2471–2482. https://doi.org/10.1212/WNL.0000000000003414

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378(9):840–851. https://doi.org/10.1056/NEJMra1708712

    Article  PubMed  Google Scholar 

  3. Dubey D, Pittock SJ, Kelly CR et al (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83(1):166–177. https://doi.org/10.1002/ana.25131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS, UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835–44. https://doi.org/10.1016/S1473-3099(10)70222-X. Erratum in: Lancet Infect Dis. 2011 Feb;11(2):79

    Article  PubMed  Google Scholar 

  5. Vogrig A, Joubert B, André-Obadia N, Gigli GL, Rheims S, Honnorat J (2019) Seizure specificities in patients with antibody-mediated autoimmune encephalitis. Epilepsia 60(8):1508–1525. https://doi.org/10.1111/epi.16282

    Article  PubMed  Google Scholar 

  6. Gu Y, Zhong M, He L et al (2019) Epidemiology of antibody-positive autoimmune encephalitis in Southwest China: a multicenter study. Front Immunol 10:2611. https://doi.org/10.3389/fimmu.2019.02611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157–165. https://doi.org/10.1016/S1474-4422(12)70310-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13(5):290–301. https://doi.org/10.1038/nrneurol.2017.43

    Article  CAS  PubMed  Google Scholar 

  9. Fredriksen JR, Carr CM, Koeller KK, Verdoorn JT, Gadoth A, Pittock SJ, Kotsenas AL (2018) MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy. Neuroradiology 60(3):239–245. https://doi.org/10.1007/s00234-018-1976-6

    Article  PubMed  Google Scholar 

  10. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54(7):899–904. https://doi.org/10.1093/cid/cir1038

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Saraya AW, Worachotsueptrakun K, Vutipongsatorn K, Sonpee C, Hemachudha T (2019) Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center. BMC Neurol 19(1):273. https://doi.org/10.1186/s12883-019-1501-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ (2017) Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol 82(1):79–92. https://doi.org/10.1002/ana.24979

    Article  CAS  PubMed  Google Scholar 

  13. Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C (2015) Imaging of autoimmune encephalitis—relevance for clinical practice and hippocampal function. Neuroscience 309:68–83. https://doi.org/10.1016/j.neuroscience.2015.05.037

    Article  CAS  PubMed  Google Scholar 

  14. Kallini JR, Hamed N, Khachemoune A (2015) Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol 54(2):130–140. https://doi.org/10.1111/ijd.12553

    Article  PubMed  Google Scholar 

  15. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67(4):470–478. https://doi.org/10.1002/ana.21917

    Article  PubMed  Google Scholar 

  16. Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D (2012) Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79(11):1094–1100. https://doi.org/10.1212/WNL.0b013e3182698cd8

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bacchi S, Franke K, Wewegama D, Needham E, Patel S, Menon D (2018) Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci 52:54–59. https://doi.org/10.1016/j.jocn.2018.03.026

    Article  PubMed  Google Scholar 

  18. Zhang W, Cui L, Wang W, Jiao Y, Zhang Y, Jiao J (2018) Early identification of anti-NMDA receptor encephalitis presenting cerebral lesions in unconventional locations on magnetic resonance imaging. J Neuroimmunol 320:101–106. https://doi.org/10.1016/j.jneuroim.2018.03.015

    Article  CAS  PubMed  Google Scholar 

  19. Li W, Wu S, Meng Q et al (2018) Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol 18(1):96. https://doi.org/10.1186/s12883-018-1099-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Probasco JC, Solnes L, Nalluri A et al (2017) Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4(4):e352. https://doi.org/10.1212/NXI.0000000000000352

    Article  PubMed  PubMed Central  Google Scholar 

  21. Moreno-Ajona D, Prieto E, Grisanti F et al (2020) 18F-FDG-PET Imaging patterns in autoimmune encephalitis: impact of image analysis on the results. Diagnostics (Basel) 10(6):356. https://doi.org/10.3390/diagnostics10060356

    Article  CAS  Google Scholar 

  22. Yin L, Han Y, Miao G, Jiang L, Xie S, Liu B (2018) CSF leukocyte, polykaryocyte, protein and glucose: their cut-offs of judging whether post-neurosurgical bacterial meningitis has been cured. Clin Neurol Neurosurg 174:198–202. https://doi.org/10.1016/j.clineuro.2018.09.023

    Article  PubMed  Google Scholar 

  23. Hrishi AP, Sethuraman M (2019) Cerebrospinal Fluid (CSF) Analysis and interpretation in neurocritical care for acute neurological conditions. Indian J Crit Care Med 23(Suppl 2):S115–S119. https://doi.org/10.5005/jp-journals-10071-23187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Breiner A, Moher D, Brooks J, Cheng W, Hegen H, Deisenhammer F, McCudden CR, Bourque PR (2019) Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review. J Neurol 266(3):616–624. https://doi.org/10.1007/s00415-018-09174-z

    Article  CAS  PubMed  Google Scholar 

  25. Blinder T, Lewerenz J (2019) Cerebrospinal fluid findings in patients with autoimmune encephalitis—a systematic analysis. Front Neurol 10:804. https://doi.org/10.3389/fneur.2019.00804

    Article  PubMed  PubMed Central  Google Scholar 

  26. Liu CY, Zhu J, Zheng XY, Ma C, Wang X (2017) Anti-N-methyl-D-aspartate receptor encephalitis: a severe, potentially reversible autoimmune encephalitis. Mediators Inflamm 2017:6361479. https://doi.org/10.1155/2017/6361479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Graus F, Saiz A, Dalmau J (2020) GAD antibodies in neurological disorders—insights and challenges. Nat Rev Neurol 16(7):353–365. https://doi.org/10.1038/s41582-020-0359-x

    Article  CAS  PubMed  Google Scholar 

  28. Ariño H, Armangué T, Petit-Pedrol M et al (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87(8):759–765. https://doi.org/10.1212/WNL.0000000000003009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13(2):167–177. https://doi.org/10.1016/S1474-4422(13)70282-5. Erratum in: Lancet Neurol. 2014;13(2):135

    Article  CAS  PubMed  Google Scholar 

  30. Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, Tao JX, Warnke P, Rose S, Towle VL, Wu S (2018) Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav 80:331–336. https://doi.org/10.1016/j.yebeh.2018.01.021

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hisham Elkhider.

Ethics declarations

Ethical approval

This research study was conducted retrospectively from data obtained for clinical purposes. The study was approved by the University of Arkansas IRB.

Informed consent

The need for an informed consent was waved by the University of Arkansas IRB because this is a restrospective chart review study. No data with identifying information is used in the study.

Conflict of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The manuscript has not been published and is not in consideration for publication in any other journal or for pre-publication. The corresponding author takes full responsibility for the data, the analyses and interpretation, and the conduct of the study. All authors had full access to all of the data. I have the right to publish any and all data separate and apart from any sponsor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elkhider, H., Sharma, R., Kapoor, N. et al. Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series. Neurol Sci 43, 2669–2680 (2022). https://doi.org/10.1007/s10072-021-05617-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05617-0

Keywords

Navigation